These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23576270)

  • 21. Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes.
    Robinson KA; Ball LE; Buse MG
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E884-90. PubMed ID: 17122093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer.
    Chaiyawat P; Netsirisawan P; Svasti J; Champattanachai V
    Front Endocrinol (Lausanne); 2014; 5():193. PubMed ID: 25426101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
    Isono T
    PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Too sweet to resist: Control of immune cell function by O-GlcNAcylation.
    de Jesus T; Shukla S; Ramakrishnan P
    Cell Immunol; 2018 Nov; 333():85-92. PubMed ID: 29887419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative
    Lin CH; Liao CC; Wang SY; Peng CY; Yeh YC; Chen MY; Chou TY
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008409
    [No Abstract]   [Full Text] [Related]  

  • 26. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T; Masson E; Pagesy P
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of O-GlcNAc in chronic diseases of aging.
    Banerjee PS; Lagerlöf O; Hart GW
    Mol Aspects Med; 2016 Oct; 51():1-15. PubMed ID: 27259471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
    Belke DD
    J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lectin Helix pomatia agglutinin recognizes O-GlcNAc containing glycoproteins in human breast cancer.
    Rambaruth ND; Greenwell P; Dwek MV
    Glycobiology; 2012 Jun; 22(6):839-48. PubMed ID: 22322011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative and Site-Specific Chemoproteomic Profiling of Protein O-GlcNAcylation in the Cell Cycle.
    Liu J; Hao Y; He Y; Li X; Sun DE; Zhang Y; Yang PY; Chen X
    ACS Chem Biol; 2021 Oct; 16(10):1917-1923. PubMed ID: 34161081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer.
    Trinca GM; Goodman ML; Papachristou EK; D'Santos CS; Chalise P; Madan R; Slawson C; Hagan CR
    Horm Cancer; 2018 Feb; 9(1):12-21. PubMed ID: 28929346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells.
    Gu Y; Gao J; Han C; Zhang X; Liu H; Ma L; Sun X; Yu W
    Mol Med Rep; 2014 Aug; 10(2):897-904. PubMed ID: 24865644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. O-GlcNAcylation site mapping by (azide-alkyne) click chemistry and mass spectrometry following intensive fractionation of skeletal muscle cells proteins.
    Deracinois B; Camoin L; Lambert M; Boyer JB; Dupont E; Bastide B; Cieniewski-Bernard C
    J Proteomics; 2018 Aug; 186():83-97. PubMed ID: 30016717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A highly effective and adjustable dual plasmid system for O-GlcNAcylated recombinant protein production in E. coli.
    Han C; Shan H; Bi C; Zhang X; Qi J; Zhang B; Gu Y; Yu W
    J Biochem; 2015 Jun; 157(6):477-84. PubMed ID: 25619971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer.
    Parker MP; Peterson KR; Slawson C
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33916244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting the "O-GlcNAc-ome"; detection, purification, and analysis of O-GlcNAc modified proteins.
    Zachara NE
    Methods Mol Biol; 2009; 534():251-79. PubMed ID: 19277546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte-specific O-GlcNAc transferase downregulation ameliorates nonalcoholic steatohepatitis by improving mitochondrial function.
    Gonzalez-Rellan MJ; Parracho T; Heras V; Rodriguez A; Fondevila MF; Novoa E; Lima N; Varela-Rey M; Senra A; Chantada-Vazquez MDP; Ameneiro C; Bernardo G; Fernandez-Ramos D; Lopitz-Otsoa F; Bilbao J; Guallar D; Fidalgo M; Bravo S; Dieguez C; Martinez-Chantar ML; Millet O; Mato JM; Schwaninger M; Prevot V; Crespo J; Frühbeck G; Iruzubieta P; Nogueiras R
    Mol Metab; 2023 Sep; 75():101776. PubMed ID: 37453647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple reaction monitoring mass spectrometry for the discovery and quantification of O-GlcNAc-modified proteins.
    Maury JJ; Ng D; Bi X; Bardor M; Choo AB
    Anal Chem; 2014 Jan; 86(1):395-402. PubMed ID: 24144119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct One-Step Fluorescent Labeling of O-GlcNAc-Modified Proteins in Live Cells Using Metabolic Intermediates.
    Tan HY; Eskandari R; Shen D; Zhu Y; Liu TW; Willems LI; Alteen MG; Madden Z; Vocadlo DJ
    J Am Chem Soc; 2018 Nov; 140(45):15300-15308. PubMed ID: 30296064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.